Xxera/openscience/retractions

Record #24683

Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1

Qian Li, Chuanwu Jiang, Yan Wang, Minghua Wei, Huijin Zheng, Yanqi Xu, Xuegang Xu, Fengyu Jia, Kai Liu, Gang Sun, Jianhua Zang, Ping Mo

Journal

Naunyn-Schmiedeberg's Archives of Pharmacology

Publisher

Original paper date

Jul 10, 2019

Original DOI

10.1007/s00210-019-01687-2

Country

Institution

Department of Gynecology, Jining No. 1 People’s Hospital, Jining, Shandong, China · Department of Interventional Radiology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China · Department of Interventional Radiology, Jinan Military General Hospital, Jinan, Shandong, China · Department of Interventional Radiology, Jining No. 2 People’s Hospital, Jining, Shandong, China · Department of Oncology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China · Department of Gynecology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Toxicology (HSC) Medicine - Obstetrics/Gynecology (HSC) Medicine - Oncology

Notes from Retraction Watch

see also: https://link.springer.com/article/10.1007/s00210-021-02056-8

Citation lifecycle

How this paper is being cited

Pre-retraction

4

Same day

1

Post-retraction

5

% post-retraction

50.0%

~2.9 citations/yr before retraction · ~0.9 citations/yr after

— citing papers

Who is still citing this work

Loading…